表紙:心臓安全サービスの市場規模、シェア、成長分析、サービス別、タイプ別、最終用途別、地域別-2025年~2032年産業予測
市場調査レポート
商品コード
1801996

心臓安全サービスの市場規模、シェア、成長分析、サービス別、タイプ別、最終用途別、地域別-2025年~2032年産業予測

Cardiac Safety Services Market Size, Share, and Growth Analysis, By Services (ECG/Holter Monitors, Blood Pressure Monitors), By Type (Integrated, Standalone), By End Use, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 192 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
心臓安全サービスの市場規模、シェア、成長分析、サービス別、タイプ別、最終用途別、地域別-2025年~2032年産業予測
出版日: 2025年08月22日
発行: SkyQuest
ページ情報: 英文 192 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓安全サービスの世界市場規模は、2023年に7億4,000万米ドルと評価され、2024年の8億2,436万米ドルから2032年には19億5,523万米ドルに成長し、予測期間(2025年~2032年)のCAGRは11.4%で成長する見通しです。

心血管疾患の予防は、医薬品開発活動や規制当局の要求の高まりと相まって、世界の心臓安全サービス市場を大きく押し上げています。アウトソーシングサービスの動向やECGデータ解析の進歩が、この需要をさらに高めています。さらに、心臓安全性モニタリングへの人工知能の統合が市場成長を促進すると予想されます。臨床試験が増加し、心血管系リスクの早期発見の必要性が高まるにつれて、サービスプロバイダーは、リアルタイムの心臓評価を容易にする包括的なECGおよび遠隔測定サービスなど、提供するサービスの幅を広げています。心臓安全性データの一元化と臨床システムとのシームレスな統合を重視することで、臨床試験の効率化とリスクの低減が図られ、規制当局による承認の迅速化を目指す製薬企業やバイオテクノロジー企業にとって、心臓安全サービスのアウトソーシングは魅力的な選択肢となります。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ
  • 技術分析
  • 顧客購買行動分析

心臓安全サービス市場規模:サービス別& CAGR(2025年~2032年)

  • 市場概要
  • 心電図/ホルターモニター
  • 血圧モニター
  • 心臓血管画像診断
  • その他

心臓安全サービス市場規模:タイプ別& CAGR(2025年~2032年)

  • 市場概要
  • 統合型
  • スタンドアロン

心臓安全サービス市場規模:最終用途別& CAGR(2025年~2032年)

  • 市場概要
  • 製薬・バイオ医薬品企業
  • CRO
  • その他

心臓安全サービス市場規模& CAGR(2025年~2032年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他の中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022年~2024年)

主要企業プロファイル

  • IQVIA
  • PPD Inc,
  • Charles River Laboratories
  • Welly sis
  • Eurofins Scientific
  • Celerion
  • Nova Research Laboratories
  • Laboratory Corporation of America Holdings
  • Konin klije Philips N.V.
  • ICON Plc.
  • SGS S.A.
  • Clario
  • Viva Link
  • Certara
  • Richmond Pharmacology
  • Biotrial

結論と提言

目次
Product Code: SQMIG35D2348

Global Cardiac Safety Services Market size was valued at USD 740.0 million in 2023 and is poised to grow from USD 824.36 million in 2024 to USD 1955.23 million by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).

The growing prevalence of cardiovascular diseases, coupled with heightened drug development activities and regulatory demands, is significantly boosting the global cardiac safety services market. The trend towards outsourcing services and advancements in ECG data analysis further enhances this demand. Additionally, the integration of artificial intelligence into cardiac safety monitoring is expected to propel market growth. As clinical trials increase and the need for early cardiovascular risk detection becomes more pressing, service providers are broadening their offerings, including comprehensive ECG and telemetry services, facilitating real-time cardiac assessments. The emphasis on centralized cardiac safety data and seamless integration with clinical systems will enhance trial efficiencies and reduce risks, making outsourcing of cardiac safety services an attractive option for pharmaceutical and biotechnology clients aiming to expedite regulatory approvals.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Safety Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Safety Services Market Segments Analysis

Global Cardiac Safety Services Market is segmented by Services, Type, End Use and region. Based on Services, the market is segmented into ECG/Holter Monitors, Blood Pressure Monitors, Cardiovascular Imaging and Others. Based on Type, the market is segmented into Integrated and Standalone. Based on End Use, the market is segmented into Pharma & Biopharma Companies, CROs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Safety Services Market

The increasing momentum in drug development, particularly within cardiovascular, oncology, and central nervous system therapies, underscores the growing necessity for cardiac safety monitoring. This heightened focus is driven by the stringent requirements imposed by regulatory bodies, necessitating comprehensive cardiac safety evaluations. As a result, there is a pronounced demand for specialized services that encompass ECG and Holter monitoring, as well as QT interval assessments. This trend reflects the industry's commitment to ensuring patient safety and the efficacy of new therapies, further reinforcing the importance of expert cardiac safety services in the drug development process.

Restraints in the Global Cardiac Safety Services Market

The Global Cardiac Safety Services market faces significant challenges due to the substantial investment required for the implementation of advanced ECG monitoring systems, telemetry devices, and AI-driven analytics platforms. This financial burden can raise the costs associated with cardiac safety services, particularly impacting small and mid-sized pharmaceutical companies. As a result, the heightened expenses may deter these companies from investing in necessary technologies and services, ultimately hindering the overall growth potential of the market. The interplay between technological advancements and financial limitations creates a restraint that may affect market dynamics and innovation.

Market Trends of the Global Cardiac Safety Services Market

The Global Cardiac Safety Services market is experiencing a notable shift towards decentralized clinical trials, significantly enhancing the adoption of remote cardiac monitoring solutions. This trend is characterized by an increased reliance on wearable ECG devices, mobile health applications, and cloud-based telemetry platforms, allowing for the efficient capture of cardiac data beyond conventional clinical environments. As a result, participants enjoy greater convenience, and researchers can access larger and more diverse participant pools while streamlining data collection processes. This evolution not only improves the overall efficiency of cardiac safety assessments but also aligns with the growing demand for innovative digital health solutions in clinical research.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Analysis
  • Customer Buying Behavior Analysis

Global Cardiac Safety Services Market Size by Services & CAGR (2025-2032)

  • Market Overview
  • ECG/Holter Monitors
  • Blood Pressure Monitors
  • Cardiovascular Imaging
  • Others

Global Cardiac Safety Services Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Integrated
  • Standalone

Global Cardiac Safety Services Market Size by End Use & CAGR (2025-2032)

  • Market Overview
  • Pharma & Biopharma Companies
  • CROs
  • Others

Global Cardiac Safety Services Market Size & CAGR (2025-2032)

  • North America (Services, Type, End Use)
    • US
    • Canada
  • Europe (Services, Type, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Services, Type, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Services, Type, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Services, Type, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • IQVIA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PPD Inc,
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Welly sis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celerion
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nova Research Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratory Corporation of America Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Konin klije Philips N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICON Plc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGS S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clario
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Viva Link
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Certara
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Richmond Pharmacology
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotrial
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations